![](https://dblp1.uni-trier.de/img/logo.320x120.png)
![search dblp search dblp](https://dblp1.uni-trier.de/img/search.dark.16x16.png)
![search dblp](https://dblp1.uni-trier.de/img/search.dark.16x16.png)
default search action
"Developing Intermediary Medication Phenotypes via Metabolomics ..."
Matthew K. Breitenstein et al. (2015)
- Matthew K. Breitenstein, Richard M. Weinshilboum, Jyotishman Pathak, Liewei Wang:
Developing Intermediary Medication Phenotypes via Metabolomics Biotechnology Using an Electronic Health Record-Linked Biobank. AMIA 2015
![](https://dblp1.uni-trier.de/img/cog.dark.24x24.png)
manage site settings
To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.